Building new Studio Companies by acquiring or licensing transformative technologies, sourcing a talented founder team, Board of Directors, mentors, and creating an actionable business model to achieve meaningful clinical inflection points. Studio Companies are structured to be self-sufficient and fully operational.
Hibiscus BioTechnology TM
Venture studio focused on building “Studio Companies” around innovative technologies.
Once projects are identified, Hibiscus BioTechnology builds new companies by obtaining rights to innovative technologies with the promise of underpinning development programs that can improve human health. Technologies, products, and business models are typically selected and designed to reach proof of concept or a meaningful clinical inflection within 1-3 years, representing significant potential value creation.